Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracksbusinessinsider·Aug 17 at 11:16 AMRGNT+2.86%
Regentis Biomaterials (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Marketbusinessinsider·Aug 14 at 10:16 AMRGNT+2.86%
Regentis Biomaterials posts investor deck on GelrinC off-the-shelf knee cartilage repair hydrogelPUBT·Aug 12 at 06:58 AMRGNT+2.86%
The Capital Restructuring Wave: Major Shifts Across Diverse SectorsGlobal Report·Aug 7 at 04:18 AMPRU+1.25%GCT+1.73%
Mid-Cap US Equities Diverge: Charles River Raises Forecast as Tech Firms Weigh RestructuringGlobal Report·Aug 6 at 04:15 AMECL+1.90%SWVL+0.68%
Specialized Operators Ramp Up Tech Integration and Sector Restructuring Amid Shifting DemandGlobal Report·Aug 5 at 04:12 AMELAB-2.10%AGNC+0.83%
The Bifurcation of Value: Decoding the Underlying Models of 10 Niche US EquitiesGlobal Report·Jul 28 at 04:12 AMBMR-1.53%EC-1.14%
Regentis wins Japanese patent allowance for GelrinC solvent-free manufacturing processPUBT·Jul 20 at 08:02 AMRGNT+2.86%
Pre-market hot trades in US stocks: Regentis Biomaterials pre-market up 7.14%, active funds but no positive newsPrice Alert·Jul 20 at 08:01 AMRGNT+2.86%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 14 at 12:05 PMGALT+5.43%CARL-1.56%
Regentis Biomaterials Shareholders Approve All Proposals at July 9 Adjourned AGMTip Ranks·Jul 9 at 03:58 PMRGNT+2.86%
Regentis Biomaterials adjourns annual shareholder meeting to July 9 after no quorumPUBT·Jul 2 at 03:31 PMRGNT+2.86%
Pre-market hot trades in US stocks: Regentis Biomaterials pre-market down 11.16%; Ambitions Enterprise pre-market up 7.05%Price Alert·Jul 2 at 05:51 AMRGNT+2.86%AHMA-5.41%
